Viewing Study NCT02427750


Ignite Creation Date: 2025-12-24 @ 4:56 PM
Ignite Modification Date: 2026-02-17 @ 11:05 PM
Study NCT ID: NCT02427750
Status: COMPLETED
Last Update Posted: 2015-10-19
First Post: 2015-04-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate Safety and Immunogenicity of Trivalent Influenza Vaccine, Formulation 2015 Southern Hemisphere, When Administered to Healthy Adult Subjects.
Sponsor: Novartis
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: V71_40S
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View